These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 23909407)
1. Bivalirudin for prevention of prosthetic valve thrombosis in heparin allergy. Palacios-Rubio J; Cano L; Vilacosta I; Vivas D J Card Surg; 2013 Sep; 28(5):520-1. PubMed ID: 23909407 [TBL] [Abstract][Full Text] [Related]
2. Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro study. Maegdefessel L; Linde T; Michel T; Hamilton K; Steinseifer U; Friedrich I; Schubert S; Hauroeder B; Raaz U; Buerke M; Werdan K; Schlitt A Thromb Haemost; 2009 Jun; 101(6):1163-9. PubMed ID: 19492162 [TBL] [Abstract][Full Text] [Related]
3. Anticoagulant monitoring techniques in a heparin-induced thrombocytopenia patient undergoing cardiopulmonary bypass using bivalirudin anticoagulant. Baker T; Chan R; Hill F J Extra Corpor Technol; 2004 Dec; 36(4):371-4. PubMed ID: 15679282 [TBL] [Abstract][Full Text] [Related]
4. Bivalirudin for Cardiopulmonary Bypass in the Setting of Heparin-Induced Thrombocytopenia and Combined Heart and Kidney Transplantation-Diagnostic and Therapeutic Challenges. Choxi AA; Patel PA; Augoustides JG; Benitez-Lopez J; Gutsche JT; Murad H; Rodriguez-Blanco YF; Fabbro M; Crookston KP; Gerstein NS J Cardiothorac Vasc Anesth; 2017 Feb; 31(1):354-364. PubMed ID: 27746016 [No Abstract] [Full Text] [Related]
5. Bivalirudin for anticoagulation in mechanical aortic valve replacement and heparin-induced thrombocytopenia. Klein M; Tomer A; Swartz A; Koyffman L; Weksler N Blood Coagul Fibrinolysis; 2006 Jun; 17(4):331-3. PubMed ID: 16651880 [TBL] [Abstract][Full Text] [Related]
6. Successful use and dosing of bivalirudin after temporary total artificial heart implantation: a case series. Crouch MA; Kasirajan V; Cahoon W; Katlaps GJ; Gunnerson KJ Pharmacotherapy; 2008 Nov; 28(11):1413-20. PubMed ID: 18957002 [TBL] [Abstract][Full Text] [Related]
7. Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass. Davis Z; Anderson R; Short D; Garber D; Valgiusti A Ann Thorac Surg; 2003 Jan; 75(1):264-5. PubMed ID: 12537226 [TBL] [Abstract][Full Text] [Related]
8. Use of bivalirudin for anticoagulation during implantation of total artificial heart. Federman M; Dragomer D; Grant S; Reemtsen B; Biniwale R J Extra Corpor Technol; 2014 Jun; 46(2):170-2. PubMed ID: 25208436 [TBL] [Abstract][Full Text] [Related]
10. Bivalirudin and transcatheter aortic valve replacement: a cautionary tale. Sangani NK; Greason KL; Torres NE; Suri RM; Mathew V Ann Thorac Surg; 2014 Dec; 98(6):2214-5. PubMed ID: 25468094 [TBL] [Abstract][Full Text] [Related]
11. Transfemoral Transcatheter Aortic Valve Replacement in a Patient With Heparin-Induced Thrombocytopenia: Intraoperative Anticoagulation Management With Bivalirudin (Angiomax). Scott B; Tam CW; Moon RS J Cardiothorac Vasc Anesth; 2015 Dec; 29(6):1603-5. PubMed ID: 25604599 [No Abstract] [Full Text] [Related]
12. Bivalirudin anticoagulation for left ventricular assist device implantation on an extracorporeal life support system in patients with heparin-induced thrombocytopenia antibodies. Ljajikj E; Zittermann A; Morshuis M; Börgermann J; Ruiz-Cano M; Schoenbrodt M; Gummert J; Koster A Interact Cardiovasc Thorac Surg; 2017 Dec; 25(6):898-904. PubMed ID: 29049666 [TBL] [Abstract][Full Text] [Related]
13. Bioline heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: the immune reaction appeared to continue unabated. Pappalardo F; Maj G; Scandroglio A; Sampietro F; Zangrillo A; Koster A Perfusion; 2009 Mar; 24(2):135-7. PubMed ID: 19654158 [TBL] [Abstract][Full Text] [Related]
14. Fulminate heparin-induced thrombocytopenia and surgery with deep hypothermic circulatory arrest using bivalirudin. Koster A; Amin-Parsa M; Kaufmann M; Meyer-Jark T; Rudloff M; Diekmann J; Georg WM; Liebke M; Schirmer U; Gummert JF Ann Thorac Surg; 2013 Mar; 95(3):1079-81. PubMed ID: 23438537 [TBL] [Abstract][Full Text] [Related]
15. Use of systemic bivalirudin with catheter-directed thrombolysis in a patient with heparin-induced thrombocytopenia: A case report. Badreldin HA; Rimsans J; Connors JM; Wiviott SD Catheter Cardiovasc Interv; 2018 Feb; 91(3):E17-E20. PubMed ID: 29068112 [TBL] [Abstract][Full Text] [Related]
16. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro. Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571 [TBL] [Abstract][Full Text] [Related]
17. Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin allergy. Pappalardo F; Franco A; Crescenzi G; Poli A; Zangrillo A; Koster A Perfusion; 2007 Jan; 22(1):67-9. PubMed ID: 17633138 [TBL] [Abstract][Full Text] [Related]
18. The use of bivalirudin for cardiopulmonary bypass anticoagulation in pediatric heparin-induced thrombocytopenia patients. Gates R; Yost P; Parker B Artif Organs; 2010 Aug; 34(8):667-9. PubMed ID: 20528853 [TBL] [Abstract][Full Text] [Related]
19. Management of anticoagulation during cardiopulmonary bypass in a patient with allergy to heparin and heparin-like compounds: a case-report. Balthazar S; Watremez C; Vigneault L; Eeckhoudt S; Pirson F; Hermans C Blood Coagul Fibrinolysis; 2014 Dec; 25(8):900-3. PubMed ID: 25004020 [TBL] [Abstract][Full Text] [Related]